Asset Allocation

As of April 30, 2026.
Type % Net
Cash 1.19%
Stock 41.94%
Bond 54.30%
Convertible 0.02%
Preferred 0.00%
Other 2.54%
View Asset Allocation
Start Trial

Market Capitalization

As of April 30, 2026
Large 75.66%
Mid 13.98%
Small 10.36%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.62%    % Emerging Markets: 3.11%    % Unidentified Markets: 9.28%

Americas 80.44%
77.36%
Canada 1.62%
United States 75.74%
3.09%
Brazil 1.35%
Chile 0.42%
Mexico 0.30%
As of April 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 7.04%
United Kingdom 1.77%
5.28%
France 1.16%
Germany 0.82%
Ireland 1.14%
Netherlands 1.00%
Sweden 0.14%
0.00%
0.00%
Greater Asia 3.24%
Japan 0.77%
0.45%
Australia 0.45%
1.67%
Taiwan 1.67%
0.35%
China 0.35%
Unidentified Region 9.28%

Bond Credit Quality Exposure

AAA 9.80%
AA 43.87%
A 13.26%
BBB 15.67%
BB 0.22%
B 0.00%
Below B 0.98%
    CCC 0.00%
    CC 0.00%
    C 0.98%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.30%
Not Available 15.90%
Short Term 0.00%
As of April 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
34.63%
Materials
5.42%
Consumer Discretionary
9.54%
Financials
16.28%
Real Estate
3.39%
Sensitive
48.00%
Communication Services
9.53%
Energy
0.00%
Industrials
12.22%
Information Technology
26.25%
Defensive
10.82%
Consumer Staples
0.00%
Health Care
10.02%
Utilities
0.80%
Not Classified
6.55%
Non Classified Equity
0.00%
Not Classified - Non Equity
6.55%
As of April 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of April 30, 2026
Type % Net
Government 39.92%
Corporate 25.60%
Securitized 32.89%
Municipal 1.26%
Other 0.34%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
4.40%
Less than 1 Year
4.40%
Intermediate
40.62%
1 to 3 Years
5.32%
3 to 5 Years
7.65%
5 to 10 Years
27.66%
Long Term
54.64%
10 to 20 Years
19.16%
20 to 30 Years
30.94%
Over 30 Years
4.55%
Other
0.34%
As of April 30, 2026
View Bond Maturity Exposure
Start Trial